BIO-key International Receives Nasdaq Extension to Regain $1 Minimum Bid Compliance
BIO-key International Inc. has announced that it received a letter from Nasdaq stating the company has not regained compliance with the minimum bid price requirement of $1.00 per share, as outlined in Nasdaq Listing Rule 5550(a)(2). Despite this, Nasdaq has granted BIO-key an additional 180-day period, until May 4, 2026, to meet the bid price rule. If the company's common stock closes at or above $1.00 per share for at least 10 consecutive business days during this period, it will regain compliance. If not, BIO-key faces potential delisting, though it would have the opportunity to appeal the decision. The company intends to monitor its stock price and may implement a reverse stock split if necessary to maintain its Nasdaq listing.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIO-key International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-033877), on November 07, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。